Heidelberg Pharma AG
XETRA:HPHA

Watchlist Manager

Heidelberg Pharma AG

XETRA:HPHA

Watchlist

Dividends

Price: 2.28 EUR 4.11% Market Closed

Market Cap: 106.3m EUR

Have any thoughts about
Heidelberg Pharma AG?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

Add Price Alert

Price Target:

Last Price: 2.28 EUR

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

HPHA Alert

Heidelberg Pharma AG

2.28

+0.09 (+4.11%)

52 Week Range	2.17 3.85
Price Target

We'll email you a reminder when the closing price reaches EUR.

Save Alert

Choose the stock you wish to monitor with a price alert.

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

Heidelberg Pharma AG

What unique competitive advantages
does Heidelberg Pharma AG hold over its rivals?

What risks and challenges
does Heidelberg Pharma AG face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of Heidelberg Pharma AG.

What unique competitive advantages
does Heidelberg Pharma AG hold over its rivals?

What risks and challenges
does Heidelberg Pharma AG face in the near future?

Has there been any significant insider trading activity
in Heidelberg Pharma AG recently?

Summarize the latest earnings call
of Heidelberg Pharma AG.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Heidelberg Pharma AG.

Provide P/S
for Heidelberg Pharma AG.

Provide P/E
for Heidelberg Pharma AG.

Provide P/OCF
for Heidelberg Pharma AG.

Provide P/FCFE
for Heidelberg Pharma AG.

Provide P/B
for Heidelberg Pharma AG.

Provide EV/S
for Heidelberg Pharma AG.

Provide EV/GP
for Heidelberg Pharma AG.

Provide EV/EBITDA
for Heidelberg Pharma AG.

Provide EV/EBIT
for Heidelberg Pharma AG.

Provide EV/OCF
for Heidelberg Pharma AG.

Provide EV/FCFF
for Heidelberg Pharma AG.

Provide EV/IC
for Heidelberg Pharma AG.

Show me price targets
for Heidelberg Pharma AG made by professional analysts.

What are the Revenue projections
for Heidelberg Pharma AG?

How accurate were the past Revenue estimates
for Heidelberg Pharma AG?

What are the Net Income projections
for Heidelberg Pharma AG?

How accurate were the past Net Income estimates
for Heidelberg Pharma AG?

What are the EPS projections
for Heidelberg Pharma AG?

How accurate were the past EPS estimates
for Heidelberg Pharma AG?

What are the EBIT projections
for Heidelberg Pharma AG?

How accurate were the past EBIT estimates
for Heidelberg Pharma AG?

Compare the revenue forecasts
for Heidelberg Pharma AG with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Heidelberg Pharma AG and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Heidelberg Pharma AG against its competitors.

Analyze the profit margins
(gross, operating, and net) of Heidelberg Pharma AG compared to its peers.

Compare the P/E ratios
of Heidelberg Pharma AG against its peers.

Discuss the investment returns and shareholder value creation
comparing Heidelberg Pharma AG with its peers.

Analyze the financial leverage
of Heidelberg Pharma AG compared to its main competitors.

Show all profitability ratios
for Heidelberg Pharma AG.

Provide ROE
for Heidelberg Pharma AG.

Provide ROA
for Heidelberg Pharma AG.

Provide ROIC
for Heidelberg Pharma AG.

Provide ROCE
for Heidelberg Pharma AG.

Provide Gross Margin
for Heidelberg Pharma AG.

Provide Operating Margin
for Heidelberg Pharma AG.

Provide Net Margin
for Heidelberg Pharma AG.

Provide FCF Margin
for Heidelberg Pharma AG.

Show all solvency ratios
for Heidelberg Pharma AG.

Provide D/E Ratio
for Heidelberg Pharma AG.

Provide D/A Ratio
for Heidelberg Pharma AG.

Provide Interest Coverage Ratio
for Heidelberg Pharma AG.

Provide Altman Z-Score Ratio
for Heidelberg Pharma AG.

Provide Quick Ratio
for Heidelberg Pharma AG.

Provide Current Ratio
for Heidelberg Pharma AG.

Provide Cash Ratio
for Heidelberg Pharma AG.

What is the historical Revenue growth
over the last 5 years for Heidelberg Pharma AG?

What is the historical Net Income growth
over the last 5 years for Heidelberg Pharma AG?

What is the current Free Cash Flow
of Heidelberg Pharma AG?

Discuss the annual earnings per share (EPS)
trend over the past five years for Heidelberg Pharma AG.

P/S
Price to Sales

12.5

Current

14.5

Median

7.7

Industry

Lower than median

Higher than industry value

Price to Sales (P/S) ratio is a valuation multiple that compares a company’s market capitalization to its revenues. It is an indicator of the value that financial markets have placed on each dollar of a company’s sales.

P/S

12.5

Market Cap

106.3m EUR

Revenue

8.5m EUR

All Countries

Forward Multiples

			Market Cap	P/S
DE		Heidelberg Pharma AG XETRA:HPHA	106.3m EUR	12.5
FR		Pharnext SCA OTC:PNEXF	6T USD	37 984 068.5
US		Abbvie Inc NYSE:ABBV	320.1B USD	5.8
US		Amgen Inc NASDAQ:AMGN	147.4B USD	4.5
US		Vertex Pharmaceuticals Inc NASDAQ:VRTX	119.4B USD	11.2
US		Gilead Sciences Inc NASDAQ:GILD	113.8B USD	4
US	E	Epizyme Inc F:EPE	94.1B EUR	1 854.7
AU		CSL Ltd ASX:CSL	135.4B AUD	6
US		Regeneron Pharmaceuticals Inc NASDAQ:REGN	82.6B USD	6
US	S	Seagen Inc F:SGT	39.3B EUR	17.9
NL		argenx SE XBRU:ARGX	34.3B EUR	18.4

				Revenue Growth
DE		Heidelberg Pharma AG XETRA:HPHA	Average P/S: 3 453 273.6 12.5	34%
FR		Pharnext SCA OTC:PNEXF	37 984 068.5	N/A
US		Abbvie Inc NYSE:ABBV	5.8	20%
US		Amgen Inc NASDAQ:AMGN	4.5	26%
US		Vertex Pharmaceuticals Inc NASDAQ:VRTX	11.2	33%
US		Gilead Sciences Inc NASDAQ:GILD	4	10%
US	E	Epizyme Inc F:EPE	1 854.7	N/A
AU		CSL Ltd ASX:CSL	6	23%
US		Regeneron Pharmaceuticals Inc NASDAQ:REGN	6	23%
US	S	Seagen Inc F:SGT	17.9	118%
NL		argenx SE XBRU:ARGX	18.4	220%

P/S Forward Multiples

Forward P/S multiple is a version of the P/S ratio that uses forecasted revenue for the P/S calculation. 1-Year, 2-Years, and 3-Years forwards use revenue forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward

P/S

10.4

2-Years Forward

P/S

11.6

3-Years Forward

P/S

Heidelberg Pharma AG
XETRA:HPHA

P/S
Price to Sales

P/S Forward Multiples

See Also

Company

Help

Tools

Stocks

Heidelberg Pharma AG XETRA:HPHA

P/S Price to Sales

P/S Forward Multiples

See Also

Company

Help

Tools

Stocks

Heidelberg Pharma AG
XETRA:HPHA

P/S
Price to Sales